Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 116

Published Date: 26 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Gastrointestinal Stromal Tumors (GSTs) Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Gastrointestinal Stromal Tumors (GSTs) Treatment industry chain, the market status of Hospitals (Surgery, Targeted Therapy), Clinics (Surgery, Targeted Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gastrointestinal Stromal Tumors (GSTs) Treatment.

Regionally, the report analyzes the Gastrointestinal Stromal Tumors (GSTs) Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gastrointestinal Stromal Tumors (GSTs) Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Gastrointestinal Stromal Tumors (GSTs) Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gastrointestinal Stromal Tumors (GSTs) Treatment industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Surgery, Targeted Therapy).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gastrointestinal Stromal Tumors (GSTs) Treatment market.

Regional Analysis: The report involves examining the Gastrointestinal Stromal Tumors (GSTs) Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gastrointestinal Stromal Tumors (GSTs) Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Gastrointestinal Stromal Tumors (GSTs) Treatment:
Company Analysis: Report covers individual Gastrointestinal Stromal Tumors (GSTs) Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gastrointestinal Stromal Tumors (GSTs) Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).

Technology Analysis: Report covers specific technologies relevant to Gastrointestinal Stromal Tumors (GSTs) Treatment. It assesses the current state, advancements, and potential future developments in Gastrointestinal Stromal Tumors (GSTs) Treatment areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gastrointestinal Stromal Tumors (GSTs) Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Gastrointestinal Stromal Tumors (GSTs) Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Surgery
Targeted Therapy
Radiation Therapy
ChemOthersapy
Others

Market segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Market segment by players, this report covers
Pfizer
Bayer
Novartis
Immunicum
Roche
AB Science
Arog Pharmaceuticals
Boston Biomedical
Sun Pharmaceutical
Natco Pharma

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gastrointestinal Stromal Tumors (GSTs) Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gastrointestinal Stromal Tumors (GSTs) Treatment, with revenue, gross margin and global market share of Gastrointestinal Stromal Tumors (GSTs) Treatment from 2019 to 2024.
Chapter 3, the Gastrointestinal Stromal Tumors (GSTs) Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gastrointestinal Stromal Tumors (GSTs) Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal Stromal Tumors (GSTs) Treatment.
Chapter 13, to describe Gastrointestinal Stromal Tumors (GSTs) Treatment research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gastrointestinal Stromal Tumors (GSTs) Treatment
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Gastrointestinal Stromal Tumors (GSTs) Treatment by Type
        1.3.1 Overview: Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Type in 2023
        1.3.3 Surgery
        1.3.4 Targeted Therapy
        1.3.5 Radiation Therapy
        1.3.6 ChemOthersapy
        1.3.7 Others
    1.4 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market by Application
        1.4.1 Overview: Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals
        1.4.3 Clinics
        1.4.4 Ambulatory Surgical Centers
        1.4.5 Others
    1.5 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size & Forecast
    1.6 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast by Region
        1.6.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region, (2019-2030)
        1.6.3 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Prospect (2019-2030)
        1.6.4 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Prospect (2019-2030)
        1.6.6 South America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
        2.1.4 Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Pfizer Recent Developments and Future Plans
    2.2 Bayer
        2.2.1 Bayer Details
        2.2.2 Bayer Major Business
        2.2.3 Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
        2.2.4 Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Bayer Recent Developments and Future Plans
    2.3 Novartis
        2.3.1 Novartis Details
        2.3.2 Novartis Major Business
        2.3.3 Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
        2.3.4 Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Novartis Recent Developments and Future Plans
    2.4 Immunicum
        2.4.1 Immunicum Details
        2.4.2 Immunicum Major Business
        2.4.3 Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
        2.4.4 Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Immunicum Recent Developments and Future Plans
    2.5 Roche
        2.5.1 Roche Details
        2.5.2 Roche Major Business
        2.5.3 Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
        2.5.4 Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Roche Recent Developments and Future Plans
    2.6 AB Science
        2.6.1 AB Science Details
        2.6.2 AB Science Major Business
        2.6.3 AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
        2.6.4 AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 AB Science Recent Developments and Future Plans
    2.7 Arog Pharmaceuticals
        2.7.1 Arog Pharmaceuticals Details
        2.7.2 Arog Pharmaceuticals Major Business
        2.7.3 Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
        2.7.4 Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Arog Pharmaceuticals Recent Developments and Future Plans
    2.8 Boston Biomedical
        2.8.1 Boston Biomedical Details
        2.8.2 Boston Biomedical Major Business
        2.8.3 Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
        2.8.4 Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Boston Biomedical Recent Developments and Future Plans
    2.9 Sun Pharmaceutical
        2.9.1 Sun Pharmaceutical Details
        2.9.2 Sun Pharmaceutical Major Business
        2.9.3 Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
        2.9.4 Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Sun Pharmaceutical Recent Developments and Future Plans
    2.10 Natco Pharma
        2.10.1 Natco Pharma Details
        2.10.2 Natco Pharma Major Business
        2.10.3 Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
        2.10.4 Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Natco Pharma Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Gastrointestinal Stromal Tumors (GSTs) Treatment by Company Revenue
        3.2.2 Top 3 Gastrointestinal Stromal Tumors (GSTs) Treatment Players Market Share in 2023
        3.2.3 Top 6 Gastrointestinal Stromal Tumors (GSTs) Treatment Players Market Share in 2023
    3.3 Gastrointestinal Stromal Tumors (GSTs) Treatment Market: Overall Company Footprint Analysis
        3.3.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Market: Region Footprint
        3.3.2 Gastrointestinal Stromal Tumors (GSTs) Treatment Market: Company Product Type Footprint
        3.3.3 Gastrointestinal Stromal Tumors (GSTs) Treatment Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Application (2019-2024)
    5.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2019-2030)
    6.2 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2019-2030)
    6.3 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country
        6.3.1 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Country (2019-2030)
        6.3.2 United States Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)
        6.3.3 Canada Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)
        6.3.4 Mexico Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2019-2030)
    7.2 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2019-2030)
    7.3 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country
        7.3.1 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Country (2019-2030)
        7.3.2 Germany Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)
        7.3.3 France Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)
        7.3.5 Russia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)
        7.3.6 Italy Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region
        8.3.1 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Region (2019-2030)
        8.3.2 China Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)
        8.3.3 Japan Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)
        8.3.4 South Korea Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)
        8.3.5 India Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)
        8.3.7 Australia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2019-2030)
    9.2 South America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2019-2030)
    9.3 South America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country
        9.3.1 South America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Country (2019-2030)
        9.3.2 Brazil Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)
        9.3.3 Argentina Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country
        10.3.1 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Country (2019-2030)
        10.3.2 Turkey Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)
        10.3.4 UAE Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Drivers
    11.2 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Restraints
    11.3 Gastrointestinal Stromal Tumors (GSTs) Treatment Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Industry Chain
    12.2 Gastrointestinal Stromal Tumors (GSTs) Treatment Upstream Analysis
    12.3 Gastrointestinal Stromal Tumors (GSTs) Treatment Midstream Analysis
    12.4 Gastrointestinal Stromal Tumors (GSTs) Treatment Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Pfizer Company Information, Head Office, and Major Competitors
    Table 6. Pfizer Major Business
    Table 7. Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
    Table 8. Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Pfizer Recent Developments and Future Plans
    Table 10. Bayer Company Information, Head Office, and Major Competitors
    Table 11. Bayer Major Business
    Table 12. Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
    Table 13. Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Bayer Recent Developments and Future Plans
    Table 15. Novartis Company Information, Head Office, and Major Competitors
    Table 16. Novartis Major Business
    Table 17. Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
    Table 18. Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Novartis Recent Developments and Future Plans
    Table 20. Immunicum Company Information, Head Office, and Major Competitors
    Table 21. Immunicum Major Business
    Table 22. Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
    Table 23. Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Immunicum Recent Developments and Future Plans
    Table 25. Roche Company Information, Head Office, and Major Competitors
    Table 26. Roche Major Business
    Table 27. Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
    Table 28. Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Roche Recent Developments and Future Plans
    Table 30. AB Science Company Information, Head Office, and Major Competitors
    Table 31. AB Science Major Business
    Table 32. AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
    Table 33. AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. AB Science Recent Developments and Future Plans
    Table 35. Arog Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 36. Arog Pharmaceuticals Major Business
    Table 37. Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
    Table 38. Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Arog Pharmaceuticals Recent Developments and Future Plans
    Table 40. Boston Biomedical Company Information, Head Office, and Major Competitors
    Table 41. Boston Biomedical Major Business
    Table 42. Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
    Table 43. Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Boston Biomedical Recent Developments and Future Plans
    Table 45. Sun Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 46. Sun Pharmaceutical Major Business
    Table 47. Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
    Table 48. Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Sun Pharmaceutical Recent Developments and Future Plans
    Table 50. Natco Pharma Company Information, Head Office, and Major Competitors
    Table 51. Natco Pharma Major Business
    Table 52. Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Product and Solutions
    Table 53. Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Natco Pharma Recent Developments and Future Plans
    Table 55. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue (USD Million) by Players (2019-2024)
    Table 56. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Share by Players (2019-2024)
    Table 57. Breakdown of Gastrointestinal Stromal Tumors (GSTs) Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Gastrointestinal Stromal Tumors (GSTs) Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 59. Head Office of Key Gastrointestinal Stromal Tumors (GSTs) Treatment Players
    Table 60. Gastrointestinal Stromal Tumors (GSTs) Treatment Market: Company Product Type Footprint
    Table 61. Gastrointestinal Stromal Tumors (GSTs) Treatment Market: Company Product Application Footprint
    Table 62. Gastrointestinal Stromal Tumors (GSTs) Treatment New Market Entrants and Barriers to Market Entry
    Table 63. Gastrointestinal Stromal Tumors (GSTs) Treatment Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (USD Million) by Type (2019-2024)
    Table 65. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Share by Type (2019-2024)
    Table 66. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Forecast by Type (2025-2030)
    Table 67. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2019-2024)
    Table 68. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Forecast by Application (2025-2030)
    Table 69. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 70. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 71. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 74. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 75. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 76. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 77. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 78. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 79. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 80. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 81. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 82. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 83. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 84. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 85. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Region (2019-2024) & (USD Million)
    Table 86. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Region (2025-2030) & (USD Million)
    Table 87. South America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 88. South America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 89. South America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 90. South America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 91. South America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 92. South America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 93. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 94. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 95. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 96. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 97. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 98. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 99. Gastrointestinal Stromal Tumors (GSTs) Treatment Raw Material
    Table 100. Key Suppliers of Gastrointestinal Stromal Tumors (GSTs) Treatment Raw Materials
List of Figures
    Figure 1. Gastrointestinal Stromal Tumors (GSTs) Treatment Picture
    Figure 2. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Type in 2023
    Figure 4. Surgery
    Figure 5. Targeted Therapy
    Figure 6. Radiation Therapy
    Figure 7. ChemOthersapy
    Figure 8. Others
    Figure 9. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 10. Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Application in 2023
    Figure 11. Hospitals Picture
    Figure 12. Clinics Picture
    Figure 13. Ambulatory Surgical Centers Picture
    Figure 14. Others Picture
    Figure 15. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 16. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 17. Global Market Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 18. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Region (2019-2030)
    Figure 19. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Region in 2023
    Figure 20. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 21. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 22. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 23. South America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 24. Middle East and Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 25. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Share by Players in 2023
    Figure 26. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 27. Global Top 3 Players Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share in 2023
    Figure 28. Global Top 6 Players Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share in 2023
    Figure 29. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Share by Type (2019-2024)
    Figure 30. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share Forecast by Type (2025-2030)
    Figure 31. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Share by Application (2019-2024)
    Figure 32. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share Forecast by Application (2025-2030)
    Figure 33. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 34. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 35. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 37. Canada Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 38. Mexico Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 39. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 40. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 41. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 42. Germany Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 43. France Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 44. United Kingdom Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 45. Russia Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 46. Italy Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 47. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 48. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 49. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Region (2019-2030)
    Figure 50. China Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 51. Japan Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 52. South Korea Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 53. India Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 54. Southeast Asia Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 55. Australia Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 56. South America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 57. South America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 58. South America Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 59. Brazil Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 60. Argentina Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 61. Middle East and Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 62. Middle East and Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 63. Middle East and Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 64. Turkey Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 65. Saudi Arabia Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 66. UAE Gastrointestinal Stromal Tumors (GSTs) Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 67. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Drivers
    Figure 68. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Restraints
    Figure 69. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Trends
    Figure 70. Porters Five Forces Analysis
    Figure 71. Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumors (GSTs) Treatment in 2023
    Figure 72. Manufacturing Process Analysis of Gastrointestinal Stromal Tumors (GSTs) Treatment
    Figure 73. Gastrointestinal Stromal Tumors (GSTs) Treatment Industrial Chain
    Figure 74. Methodology
    Figure 75. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Pfizer
Bayer
Novartis
Immunicum
Roche
AB Science
Arog Pharmaceuticals
Boston Biomedical
Sun Pharmaceutical
Natco Pharma

Related Reports

Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 15 Jan 2023

date Medical Care

A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine.

Global Gastrointestinal Stromal Tumors (GSTs) Treatment Supply, Demand and Key Producers, 2023-2029

Global Gastrointestinal Stromal Tumors (GSTs) Treatment Supply, Demand and Key Producers, 2023-2029

date 31 Jan 2023

date Medical Care

A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine.

Global Gastrointestinal Stromal Tumors (GSTs) Treatment Supply, Demand and Key Producers, 2024-2030

Global Gastrointestinal Stromal Tumors (GSTs) Treatment Supply, Demand and Key Producers, 2024-2030

date 26 Jan 2024

date Medical Care

The global Gastrointestinal Stromal Tumors (GSTs) Treatment market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Gastrointestinal Stromal Tumors (GSTs) Treatment

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>